Peptide Science ARA-290 for sale – here now for the excellent price of $95.00! If you want to save more money then see our buy-in bulk offers below. We supply a range of great offers for example:
Take advantage of even more savings when you buy with us such as; free shipping if you live in the USA when you spend over $200.00! But, don’t be disappointed if you live outside of the USA, we ship to most countries for the flat rate of $15.00. Plus when your spend over $300 you get 1 FREE Bacteriostatic Water
If you are in the research and development community and want to buy ARA290 peptides for research, we are the best choice. USA Peptides supplies over 100 research amino acids, proteins, and peptides manufactured by leading US-based research company Peptide Sciences. All of the research products are tested for purity so are safe and free of additives. If you work in this sector of education and scientific research you are guaranteed the best quality research chemicals here!
What is ARA-290 Dosage Achieving in Research?
ARA-290 is a peptide presently being researched for treating neuropathic pain in patients with sarcoidosis. Tests are underway to treat the disease and find a long-term cure for this condition.
The peptide ARA-290 can promote blood vessel growth and cell survival, change blood pressure, and produce neuroprotective effects in diabetic neuropathy.
ARA 290 provides neuroprotective and pain relief effects with no stimulation to red blood cell production. ARA-290 is an exciting research peptide that shows impressive results in studies in controlling neuropathic pain. In addition, further investigations show ARA-290 is a potential wound repair treatment for chronic diabetes and the condition Lupus.
ARA 290 Neuropathy Pain Reliefs
ARA-290 is currently being tested for its safety as a treatment for neuropathic pain for sarcoidosis patients. The pain mostly affects nerve fibers and Sarcoidosis is a chronic systemic granulomatous disease affecting young to older individuals. The condition is progressive and can lead to significant organ impairment, nerve fiber loss, disabling neuropathic symptoms, and pain being the main complaint. These symptoms cause a considerable loss of quality of life and often the inability to work. While mortality is not common, it can increase over time.
ARA 290 is a peptide that has shown the potential to relieve neuropathic pain associated with conditions such as sarcoidosis. It modulates the innate repair receptor (IRR), which helps regulate inflammatory responses and tissue repair. ARA 290 can reduce pain and improve the quality of life in individuals with neuropathy. While further research is needed to establish its efficacy and safety, initial studies suggest that ARA 290 may hold promise as a therapeutic option for neuropathic pain management.
Cibinetide (ARA 290)
ARA 290 is also known as Cabinetide, and is classed as a research substance that comes under the class of drugs including:
- Cardiovascular therapies
- Eye disorder therapies
- Mechanism of Action is Erythropoietin receptor agonists
- Status in research is to treat Sarcoidosis, Neuropathic pain, and Transplant rejection.
A Guide to Cibinetide
Cibinetide is a synthetic peptide derived from the amino acid sequence of the endogenous peptide AcSDKP (N-acetyl-seryl-aspartyl-lysyl-proline). In studies, it has the potential to treat inflammatory and autoimmune conditions.
Cibinetide is known for its ability to modulate the innate repair receptor (IRR) and promote tissue repair processes. It has shown anti-inflammatory effects, the ability to reduce oxidative stress, and the potential to promote neuroprotection and tissue regeneration. Studies show Cibinetide effectively treats conditions such as sarcoidosis, diabetic neuropathy, and other inflammatory disorders.
What is the Benefit of ARA290 Peptide?
ARA 290 is a peptide studied for its potential therapeutic benefits in various inflammatory and autoimmune conditions. Here are some potential benefits associated with ARA 290:
- Anti-inflammatory effects: ARA 290 has shown anti-inflammatory properties and, in studies, shows its potential to modulate immune responses and reduce inflammation in certain diseases.
- Neuroprotective effects: ARA 290 has demonstrated neuroprotective properties in preclinical studies. It may help protect nerve cells from damage or degeneration and promote neuronal survival.
- Pain relief: Studies show ARA 290 can potentially alleviate neuropathic pain, which is pain from damage or dysfunction of the nervous system. It may help reduce pain signals and improve pain management in certain conditions.
- Tissue repair and regeneration: ARA 290 can promote tissue repair and regeneration. It can help heal damaged tissues and contribute to overall tissue health.
What is the Mechanism of Action of Ara 290?
ARA 290 exerts its therapeutic effects by modulating the innate repair receptor (IRR), a receptor involved in tissue repair and inflammation regulation. ARA 290 binds to the IRR, activating downstream signaling pathways and promoting anti-inflammatory responses and tissue repair processes.
By binding to the IRR, ARA 290 helps modulate immune responses, reduce inflammation, and promote tissue healing. It can downregulate pro-inflammatory cytokines and upregulate anti-inflammatory cytokines, shifting the balance towards a more favorable anti-inflammatory state.
Additionally, ARA 290 has shown some neuroprotective effects, promoting neuronal survival and reducing pain signals. The exact details of the mechanism of action of ARA 290 are under investigation, and the interaction with the IRR holds promise. It has potential therapeutic results in various inflammatory and autoimmune conditions and neuropathic pain management.
Does ARA-290 Have Side Effects?
ARA-290 is a peptide studied for its therapeutic potential, but information on its side effects is limited. Since it is a relatively new substance, comprehensive data on its safety profile and potential side effects in humans are still being studied. However, in clinical trials and preclinical studies conducted thus far, ARA-290 has generally been well-tolerated, with minimal adverse effects.
It’s important to note that individual medication responses can vary, and some individuals may experience side effects while others may not. Suppose you are considering using ARA-290 or any other medication. In that case, consulting with a healthcare professional who can provide personalized advice based on your medical history and current health condition is crucial.
Furthermore, ARA-290 is under investigation and has no approval for widespread medical use.
ARA-290’s safety and potential side effects still need to be fully understood. Ongoing research and clinical trials are necessary to gather more data and determine the safety profile of ARA-290 in different patient populations.
ARA 290, a research peptide designed to interact specifically with the innate repair receptor that mediates tissue protection. ARA 290 has shown effective as a treatment in clinical studies of metabolic control and neuropathy. Further trials are needed with ARA 290 before it can be used as a treatment, but it is looking hopeful for the future.